nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylnaltrexone—Naloxone—TLR4—rheumatoid arthritis	0.0257	0.889	CrCbGaD
Methylnaltrexone—Redness—Hydrocortisone—rheumatoid arthritis	0.0132	0.0258	CcSEcCtD
Methylnaltrexone—Stinging—Cyclosporine—rheumatoid arthritis	0.0124	0.0242	CcSEcCtD
Methylnaltrexone—Flatulence—Auranofin—rheumatoid arthritis	0.0124	0.0241	CcSEcCtD
Methylnaltrexone—Stinging—Prednisolone—rheumatoid arthritis	0.0113	0.022	CcSEcCtD
Methylnaltrexone—Stinging—Hydrocortisone—rheumatoid arthritis	0.011	0.0215	CcSEcCtD
Methylnaltrexone—Pain—Ergocalciferol—rheumatoid arthritis	0.0107	0.0209	CcSEcCtD
Methylnaltrexone—Stinging—Triamcinolone—rheumatoid arthritis	0.0104	0.0202	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Penicillamine—rheumatoid arthritis	0.0098	0.0191	CcSEcCtD
Methylnaltrexone—Stinging—Dexamethasone—rheumatoid arthritis	0.00943	0.0184	CcSEcCtD
Methylnaltrexone—Stinging—Betamethasone—rheumatoid arthritis	0.00943	0.0184	CcSEcCtD
Methylnaltrexone—Skin disorder—Penicillamine—rheumatoid arthritis	0.00919	0.0179	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Auranofin—rheumatoid arthritis	0.00837	0.0163	CcSEcCtD
Methylnaltrexone—Abdominal pain—Auranofin—rheumatoid arthritis	0.0081	0.0158	CcSEcCtD
Methylnaltrexone—Nausea—Ergocalciferol—rheumatoid arthritis	0.00746	0.0145	CcSEcCtD
Methylnaltrexone—Diarrhoea—Auranofin—rheumatoid arthritis	0.00701	0.0136	CcSEcCtD
Methylnaltrexone—Vomiting—Auranofin—rheumatoid arthritis	0.00651	0.0127	CcSEcCtD
Methylnaltrexone—Diarrhoea—Penicillamine—rheumatoid arthritis	0.00647	0.0126	CcSEcCtD
Methylnaltrexone—Nausea—Auranofin—rheumatoid arthritis	0.00608	0.0118	CcSEcCtD
Methylnaltrexone—Vomiting—Penicillamine—rheumatoid arthritis	0.00601	0.0117	CcSEcCtD
Methylnaltrexone—Nausea—Penicillamine—rheumatoid arthritis	0.00562	0.0109	CcSEcCtD
Methylnaltrexone—Flatulence—Leflunomide—rheumatoid arthritis	0.00561	0.0109	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—rheumatoid arthritis	0.0051	0.00993	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—rheumatoid arthritis	0.00482	0.00938	CcSEcCtD
Methylnaltrexone—Skin disorder—Azathioprine—rheumatoid arthritis	0.00478	0.00931	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Leflunomide—rheumatoid arthritis	0.00456	0.00888	CcSEcCtD
Methylnaltrexone—Skin disorder—Leflunomide—rheumatoid arthritis	0.00452	0.00879	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Leflunomide—rheumatoid arthritis	0.00449	0.00875	CcSEcCtD
Methylnaltrexone—Flatulence—Cyclosporine—rheumatoid arthritis	0.00433	0.00843	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Azathioprine—rheumatoid arthritis	0.00425	0.00828	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Azathioprine—rheumatoid arthritis	0.00403	0.00784	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Leflunomide—rheumatoid arthritis	0.00401	0.00781	CcSEcCtD
Methylnaltrexone—Erythema—Prednisolone—rheumatoid arthritis	0.004	0.00779	CcSEcCtD
Methylnaltrexone—Pain—Leflunomide—rheumatoid arthritis	0.00398	0.00774	CcSEcCtD
Methylnaltrexone—Erythema—Hydrocortisone—rheumatoid arthritis	0.00391	0.00761	CcSEcCtD
Methylnaltrexone—Abdominal pain—Azathioprine—rheumatoid arthritis	0.00389	0.00758	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Leflunomide—rheumatoid arthritis	0.0038	0.0074	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—rheumatoid arthritis	0.00372	0.00724	CcSEcCtD
Methylnaltrexone—Erythema—Triamcinolone—rheumatoid arthritis	0.00368	0.00716	CcSEcCtD
Methylnaltrexone—Abdominal pain—Leflunomide—rheumatoid arthritis	0.00368	0.00716	CcSEcCtD
Methylnaltrexone—Erythema—Methylprednisolone—rheumatoid arthritis	0.00367	0.00715	CcSEcCtD
Methylnaltrexone—Oedema—Cyclosporine—rheumatoid arthritis	0.00359	0.00699	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Cyclosporine—rheumatoid arthritis	0.00352	0.00685	CcSEcCtD
Methylnaltrexone—Skin disorder—Cyclosporine—rheumatoid arthritis	0.00349	0.00679	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Cyclosporine—rheumatoid arthritis	0.00347	0.00675	CcSEcCtD
Methylnaltrexone—Diarrhoea—Azathioprine—rheumatoid arthritis	0.00337	0.00656	CcSEcCtD
Methylnaltrexone—Erythema—Dexamethasone—rheumatoid arthritis	0.00334	0.0065	CcSEcCtD
Methylnaltrexone—Erythema—Betamethasone—rheumatoid arthritis	0.00334	0.0065	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—rheumatoid arthritis	0.0033	0.00643	CcSEcCtD
Methylnaltrexone—Oedema—Prednisolone—rheumatoid arthritis	0.00327	0.00636	CcSEcCtD
Methylnaltrexone—Dizziness—Azathioprine—rheumatoid arthritis	0.00326	0.00634	CcSEcCtD
Methylnaltrexone—Naloxone—ALB—rheumatoid arthritis	0.0032	0.111	CrCbGaD
Methylnaltrexone—Oedema—Hydrocortisone—rheumatoid arthritis	0.00319	0.00621	CcSEcCtD
Methylnaltrexone—Diarrhoea—Leflunomide—rheumatoid arthritis	0.00318	0.00619	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Prednisolone—rheumatoid arthritis	0.00316	0.00615	CcSEcCtD
Methylnaltrexone—Vomiting—Azathioprine—rheumatoid arthritis	0.00313	0.00609	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Hydrocortisone—rheumatoid arthritis	0.00313	0.00609	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—rheumatoid arthritis	0.0031	0.00604	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Cyclosporine—rheumatoid arthritis	0.0031	0.00603	CcSEcCtD
Methylnaltrexone—Skin disorder—Hydrocortisone—rheumatoid arthritis	0.0031	0.00603	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Hydrocortisone—rheumatoid arthritis	0.00308	0.006	CcSEcCtD
Methylnaltrexone—Dizziness—Leflunomide—rheumatoid arthritis	0.00307	0.00599	CcSEcCtD
Methylnaltrexone—Pain—Cyclosporine—rheumatoid arthritis	0.00307	0.00597	CcSEcCtD
Methylnaltrexone—Oedema—Triamcinolone—rheumatoid arthritis	0.003	0.00585	CcSEcCtD
Methylnaltrexone—Vomiting—Leflunomide—rheumatoid arthritis	0.00296	0.00576	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	0.00294	0.00572	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Cyclosporine—rheumatoid arthritis	0.00293	0.00571	CcSEcCtD
Methylnaltrexone—Nausea—Azathioprine—rheumatoid arthritis	0.00292	0.00569	CcSEcCtD
Methylnaltrexone—Skin disorder—Methylprednisolone—rheumatoid arthritis	0.00291	0.00567	CcSEcCtD
Methylnaltrexone—Erythema—Prednisone—rheumatoid arthritis	0.00291	0.00566	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Triamcinolone—rheumatoid arthritis	0.0029	0.00565	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Methylprednisolone—rheumatoid arthritis	0.0029	0.00564	CcSEcCtD
Methylnaltrexone—Abdominal pain—Cyclosporine—rheumatoid arthritis	0.00284	0.00552	CcSEcCtD
Methylnaltrexone—Pain—Prednisolone—rheumatoid arthritis	0.00279	0.00544	CcSEcCtD
Methylnaltrexone—Nausea—Leflunomide—rheumatoid arthritis	0.00276	0.00538	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.00275	0.00536	CcSEcCtD
Methylnaltrexone—Pain—Hydrocortisone—rheumatoid arthritis	0.00273	0.00531	CcSEcCtD
Methylnaltrexone—Oedema—Dexamethasone—rheumatoid arthritis	0.00272	0.0053	CcSEcCtD
Methylnaltrexone—Oedema—Betamethasone—rheumatoid arthritis	0.00272	0.0053	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.00267	0.0052	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.00267	0.0052	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	0.00263	0.00513	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Betamethasone—rheumatoid arthritis	0.00263	0.00513	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	0.00261	0.00508	CcSEcCtD
Methylnaltrexone—Pain—Triamcinolone—rheumatoid arthritis	0.00257	0.005	CcSEcCtD
Methylnaltrexone—Abdominal pain—Hydrocortisone—rheumatoid arthritis	0.00252	0.00491	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.00246	0.00479	CcSEcCtD
Methylnaltrexone—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.00246	0.00478	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	0.00245	0.00477	CcSEcCtD
Methylnaltrexone—Erythema—Methotrexate—rheumatoid arthritis	0.00243	0.00473	CcSEcCtD
Methylnaltrexone—Dizziness—Cyclosporine—rheumatoid arthritis	0.00237	0.00462	CcSEcCtD
Methylnaltrexone—Oedema—Prednisone—rheumatoid arthritis	0.00237	0.00462	CcSEcCtD
Methylnaltrexone—Abdominal pain—Methylprednisolone—rheumatoid arthritis	0.00237	0.00461	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.00235	0.00458	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.00235	0.00458	CcSEcCtD
Methylnaltrexone—Pain—Betamethasone—rheumatoid arthritis	0.00233	0.00454	CcSEcCtD
Methylnaltrexone—Pain—Dexamethasone—rheumatoid arthritis	0.00233	0.00454	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Prednisone—rheumatoid arthritis	0.00233	0.00453	CcSEcCtD
Methylnaltrexone—Skin disorder—Prednisone—rheumatoid arthritis	0.0023	0.00449	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Prednisone—rheumatoid arthritis	0.00229	0.00447	CcSEcCtD
Methylnaltrexone—Vomiting—Cyclosporine—rheumatoid arthritis	0.00228	0.00444	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	0.00223	0.00434	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	0.00223	0.00434	CcSEcCtD
Methylnaltrexone—Diarrhoea—Hydrocortisone—rheumatoid arthritis	0.00218	0.00425	CcSEcCtD
Methylnaltrexone—Dizziness—Prednisolone—rheumatoid arthritis	0.00216	0.0042	CcSEcCtD
Methylnaltrexone—Abdominal pain—Betamethasone—rheumatoid arthritis	0.00215	0.00419	CcSEcCtD
Methylnaltrexone—Abdominal pain—Dexamethasone—rheumatoid arthritis	0.00215	0.00419	CcSEcCtD
Methylnaltrexone—Nausea—Cyclosporine—rheumatoid arthritis	0.00213	0.00415	CcSEcCtD
Methylnaltrexone—Dizziness—Hydrocortisone—rheumatoid arthritis	0.00211	0.00411	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	0.00205	0.004	CcSEcCtD
Methylnaltrexone—Diarrhoea—Methylprednisolone—rheumatoid arthritis	0.00205	0.00399	CcSEcCtD
Methylnaltrexone—Vomiting—Hydrocortisone—rheumatoid arthritis	0.00203	0.00395	CcSEcCtD
Methylnaltrexone—Dizziness—Triamcinolone—rheumatoid arthritis	0.00199	0.00387	CcSEcCtD
Methylnaltrexone—Dizziness—Methylprednisolone—rheumatoid arthritis	0.00198	0.00386	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Methotrexate—rheumatoid arthritis	0.00194	0.00379	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Prednisone—rheumatoid arthritis	0.00194	0.00378	CcSEcCtD
Methylnaltrexone—Nausea—Prednisolone—rheumatoid arthritis	0.00194	0.00378	CcSEcCtD
Methylnaltrexone—Skin disorder—Methotrexate—rheumatoid arthritis	0.00193	0.00375	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Methotrexate—rheumatoid arthritis	0.00192	0.00373	CcSEcCtD
Methylnaltrexone—Vomiting—Triamcinolone—rheumatoid arthritis	0.00191	0.00372	CcSEcCtD
Methylnaltrexone—Vomiting—Methylprednisolone—rheumatoid arthritis	0.0019	0.00371	CcSEcCtD
Methylnaltrexone—Nausea—Hydrocortisone—rheumatoid arthritis	0.00189	0.00369	CcSEcCtD
Methylnaltrexone—Abdominal pain—Prednisone—rheumatoid arthritis	0.00188	0.00365	CcSEcCtD
Methylnaltrexone—Diarrhoea—Betamethasone—rheumatoid arthritis	0.00186	0.00363	CcSEcCtD
Methylnaltrexone—Diarrhoea—Dexamethasone—rheumatoid arthritis	0.00186	0.00363	CcSEcCtD
Methylnaltrexone—Dizziness—Betamethasone—rheumatoid arthritis	0.0018	0.00351	CcSEcCtD
Methylnaltrexone—Dizziness—Dexamethasone—rheumatoid arthritis	0.0018	0.00351	CcSEcCtD
Methylnaltrexone—Nausea—Triamcinolone—rheumatoid arthritis	0.00178	0.00347	CcSEcCtD
Methylnaltrexone—Nausea—Methylprednisolone—rheumatoid arthritis	0.00178	0.00346	CcSEcCtD
Methylnaltrexone—Vomiting—Betamethasone—rheumatoid arthritis	0.00173	0.00337	CcSEcCtD
Methylnaltrexone—Vomiting—Dexamethasone—rheumatoid arthritis	0.00173	0.00337	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	0.00171	0.00333	CcSEcCtD
Methylnaltrexone—Pain—Methotrexate—rheumatoid arthritis	0.0017	0.0033	CcSEcCtD
Methylnaltrexone—Diarrhoea—Prednisone—rheumatoid arthritis	0.00162	0.00316	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	0.00162	0.00316	CcSEcCtD
Methylnaltrexone—Nausea—Betamethasone—rheumatoid arthritis	0.00162	0.00315	CcSEcCtD
Methylnaltrexone—Nausea—Dexamethasone—rheumatoid arthritis	0.00162	0.00315	CcSEcCtD
Methylnaltrexone—Dizziness—Prednisone—rheumatoid arthritis	0.00157	0.00305	CcSEcCtD
Methylnaltrexone—Abdominal pain—Methotrexate—rheumatoid arthritis	0.00157	0.00305	CcSEcCtD
Methylnaltrexone—Vomiting—Prednisone—rheumatoid arthritis	0.00151	0.00294	CcSEcCtD
Methylnaltrexone—Nausea—Prednisone—rheumatoid arthritis	0.00141	0.00274	CcSEcCtD
Methylnaltrexone—Diarrhoea—Methotrexate—rheumatoid arthritis	0.00136	0.00264	CcSEcCtD
Methylnaltrexone—Dizziness—Methotrexate—rheumatoid arthritis	0.00131	0.00255	CcSEcCtD
Methylnaltrexone—Vomiting—Methotrexate—rheumatoid arthritis	0.00126	0.00245	CcSEcCtD
Methylnaltrexone—Nausea—Methotrexate—rheumatoid arthritis	0.00118	0.00229	CcSEcCtD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—rheumatoid arthritis	0.000701	0.00153	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CX3CR1—rheumatoid arthritis	0.000696	0.00152	CbGpPWpGaD
Methylnaltrexone—OPRM1—G alpha (i) signalling events—POMC—rheumatoid arthritis	0.000689	0.00151	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—CXCL10—rheumatoid arthritis	0.000688	0.0015	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—C3—rheumatoid arthritis	0.000685	0.0015	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—IL2RB—rheumatoid arthritis	0.00067	0.00146	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CCR6—rheumatoid arthritis	0.00067	0.00146	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CXCL6—rheumatoid arthritis	0.000661	0.00145	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CXCL13—rheumatoid arthritis	0.00066	0.00144	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—rheumatoid arthritis	0.000648	0.00142	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—C5—rheumatoid arthritis	0.000647	0.00141	CbGpPWpGaD
Methylnaltrexone—OPRM1—TCR Signaling Pathway—IL6—rheumatoid arthritis	0.000645	0.00141	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL2—rheumatoid arthritis	0.000634	0.00139	CbGpPWpGaD
Methylnaltrexone—OPRM1—Peptide ligand-binding receptors—CXCL8—rheumatoid arthritis	0.000632	0.00138	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—CCR5—rheumatoid arthritis	0.000632	0.00138	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CCL21—rheumatoid arthritis	0.000631	0.00138	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—SYVN1—rheumatoid arthritis	0.000631	0.00138	CbGpPWpGaD
Methylnaltrexone—OPRK1—G alpha (i) signalling events—CXCL8—rheumatoid arthritis	0.000631	0.00138	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—IL2RB—rheumatoid arthritis	0.000623	0.00136	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—C3—rheumatoid arthritis	0.000617	0.00135	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CXCL2—rheumatoid arthritis	0.000613	0.00134	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CCR6—rheumatoid arthritis	0.000608	0.00133	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—TAGAP—rheumatoid arthritis	0.000605	0.00132	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—C5—rheumatoid arthritis	0.000602	0.00132	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—SAA1—rheumatoid arthritis	0.000599	0.00131	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PDE2A—rheumatoid arthritis	0.000593	0.0013	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—CCL5—rheumatoid arthritis	0.000593	0.0013	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CX3CR1—rheumatoid arthritis	0.000588	0.00129	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—IL2RB—rheumatoid arthritis	0.000566	0.00124	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CCR6—rheumatoid arthritis	0.000566	0.00124	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PLB1—rheumatoid arthritis	0.000566	0.00124	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CXCL2—rheumatoid arthritis	0.000556	0.00122	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CCL3—rheumatoid arthritis	0.000556	0.00122	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—rheumatoid arthritis	0.000548	0.0012	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—C5—rheumatoid arthritis	0.000547	0.00119	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—SAA1—rheumatoid arthritis	0.000544	0.00119	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—rheumatoid arthritis	0.000536	0.00117	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—CCR5—rheumatoid arthritis	0.000534	0.00117	CbGpPWpGaD
Methylnaltrexone—OPRM1—G alpha (i) signalling events—CXCL8—rheumatoid arthritis	0.000533	0.00117	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—RBPJ—rheumatoid arthritis	0.000522	0.00114	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—C3—rheumatoid arthritis	0.000522	0.00114	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CXCL12—rheumatoid arthritis	0.000521	0.00114	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—BDKRB2—rheumatoid arthritis	0.000521	0.00114	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CXCL2—rheumatoid arthritis	0.000518	0.00113	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—ADRBK1—rheumatoid arthritis	0.000515	0.00113	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CCR6—rheumatoid arthritis	0.000514	0.00112	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—SAA1—rheumatoid arthritis	0.000506	0.00111	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—rheumatoid arthritis	0.000502	0.0011	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PDE2A—rheumatoid arthritis	0.000501	0.0011	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—POMC—rheumatoid arthritis	0.000494	0.00108	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—RASGRP1—rheumatoid arthritis	0.000486	0.00106	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—CCL2—rheumatoid arthritis	0.000483	0.00106	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PLB1—rheumatoid arthritis	0.000478	0.00105	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—PRKCQ—rheumatoid arthritis	0.000475	0.00104	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CXCL12—rheumatoid arthritis	0.000473	0.00103	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—BDKRB2—rheumatoid arthritis	0.000473	0.00103	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CXCL2—rheumatoid arthritis	0.00047	0.00103	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CCL3—rheumatoid arthritis	0.00047	0.00103	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—ADRBK1—rheumatoid arthritis	0.000468	0.00102	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—FADS2—rheumatoid arthritis	0.000461	0.00101	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CXCL13—rheumatoid arthritis	0.000461	0.00101	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CXCL10—rheumatoid arthritis	0.00046	0.00101	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—SAA1—rheumatoid arthritis	0.00046	0.00101	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—RBPJ—rheumatoid arthritis	0.000441	0.000964	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—RASGRP1—rheumatoid arthritis	0.000441	0.000964	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—BDKRB2—rheumatoid arthritis	0.00044	0.000962	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CXCL12—rheumatoid arthritis	0.00044	0.000962	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—ADRBK1—rheumatoid arthritis	0.000435	0.000951	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—PRKCQ—rheumatoid arthritis	0.000432	0.000943	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—rheumatoid arthritis	0.000424	0.000926	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CXCL10—rheumatoid arthritis	0.000418	0.000914	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—POMC—rheumatoid arthritis	0.000417	0.000912	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—TLE3—rheumatoid arthritis	0.000415	0.000908	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—IRAK1—rheumatoid arthritis	0.000415	0.000908	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CX3CR1—rheumatoid arthritis	0.000411	0.000898	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—RASGRP1—rheumatoid arthritis	0.000411	0.000897	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—CCL2—rheumatoid arthritis	0.000408	0.000892	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—PRKCQ—rheumatoid arthritis	0.000402	0.000878	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CXCL12—rheumatoid arthritis	0.0004	0.000874	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—BDKRB2—rheumatoid arthritis	0.0004	0.000874	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CCL5—rheumatoid arthritis	0.000396	0.000866	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—IL2RB—rheumatoid arthritis	0.000396	0.000865	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—ADRBK1—rheumatoid arthritis	0.000395	0.000864	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Biological oxidations—POMC—rheumatoid arthritis	0.000391	0.000855	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CSF2—rheumatoid arthritis	0.00039	0.000853	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CXCL13—rheumatoid arthritis	0.00039	0.000852	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CXCL10—rheumatoid arthritis	0.000389	0.00085	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—C5—rheumatoid arthritis	0.000382	0.000835	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—CXCL8—rheumatoid arthritis	0.000382	0.000835	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—MMP3—rheumatoid arthritis	0.000381	0.000833	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—NFATC1—rheumatoid arthritis	0.000376	0.000822	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—RASGRP1—rheumatoid arthritis	0.000373	0.000815	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—PRKCQ—rheumatoid arthritis	0.000365	0.000797	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CCL5—rheumatoid arthritis	0.00036	0.000787	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CCR6—rheumatoid arthritis	0.000359	0.000785	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CCR5—rheumatoid arthritis	0.000357	0.00078	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CSF2—rheumatoid arthritis	0.000354	0.000775	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CXCL10—rheumatoid arthritis	0.000353	0.000772	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—IL2RA—rheumatoid arthritis	0.000352	0.000769	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—IRAK1—rheumatoid arthritis	0.000351	0.000767	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—TLE3—rheumatoid arthritis	0.000351	0.000767	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—NCF2—rheumatoid arthritis	0.00035	0.000764	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—C3—rheumatoid arthritis	0.000349	0.000763	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CX3CR1—rheumatoid arthritis	0.000347	0.000759	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—TRAF6—rheumatoid arthritis	0.000341	0.000744	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—SH2B3—rheumatoid arthritis	0.000341	0.000744	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—GZMB—rheumatoid arthritis	0.000338	0.00074	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CCL5—rheumatoid arthritis	0.000335	0.000732	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—IL2RB—rheumatoid arthritis	0.000334	0.000731	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CSF2—rheumatoid arthritis	0.00033	0.000721	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CCL3—rheumatoid arthritis	0.000329	0.000718	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CXCL2—rheumatoid arthritis	0.000329	0.000718	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CCR5—rheumatoid arthritis	0.000324	0.000709	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—C5—rheumatoid arthritis	0.000323	0.000706	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—CXCL8—rheumatoid arthritis	0.000323	0.000705	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—MMP3—rheumatoid arthritis	0.000322	0.000704	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—SAA1—rheumatoid arthritis	0.000321	0.000702	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—IL2RA—rheumatoid arthritis	0.000319	0.000698	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NFATC1—rheumatoid arthritis	0.000318	0.000694	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—C3—rheumatoid arthritis	0.000317	0.000692	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—NCF1—rheumatoid arthritis	0.000315	0.000688	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PLD4—rheumatoid arthritis	0.000308	0.000673	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CCL5—rheumatoid arthritis	0.000304	0.000665	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CCR6—rheumatoid arthritis	0.000304	0.000664	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CD28—rheumatoid arthritis	0.000303	0.000661	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CCR5—rheumatoid arthritis	0.000302	0.000659	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CSF2—rheumatoid arthritis	0.0003	0.000655	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—IL2RA—rheumatoid arthritis	0.000297	0.00065	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ACAN—rheumatoid arthritis	0.000297	0.00065	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NCF2—rheumatoid arthritis	0.000295	0.000646	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—C3—rheumatoid arthritis	0.000295	0.000644	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—SH2B3—rheumatoid arthritis	0.000288	0.000629	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—TRAF6—rheumatoid arthritis	0.000288	0.000629	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—GZMB—rheumatoid arthritis	0.000286	0.000625	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—UBE2D1—rheumatoid arthritis	0.000285	0.000623	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—SLC25A12—rheumatoid arthritis	0.00028	0.000611	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CXCL12—rheumatoid arthritis	0.000279	0.000611	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—BDKRB2—rheumatoid arthritis	0.000279	0.000611	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—POMC—rheumatoid arthritis	0.000279	0.00061	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CXCL2—rheumatoid arthritis	0.000278	0.000607	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CCL3—rheumatoid arthritis	0.000278	0.000607	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—IL6ST—rheumatoid arthritis	0.000277	0.000605	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—ADRBK1—rheumatoid arthritis	0.000276	0.000604	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CCR5—rheumatoid arthritis	0.000274	0.000599	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PTGES—rheumatoid arthritis	0.000272	0.000594	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—GC—rheumatoid arthritis	0.000272	0.000594	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—SAA1—rheumatoid arthritis	0.000272	0.000594	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—IL2RA—rheumatoid arthritis	0.00027	0.00059	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—C3—rheumatoid arthritis	0.000268	0.000585	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NCF1—rheumatoid arthritis	0.000266	0.000581	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—RASGRP1—rheumatoid arthritis	0.000261	0.00057	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—SYK—rheumatoid arthritis	0.00026	0.000568	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CD28—rheumatoid arthritis	0.000256	0.000559	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PRKCQ—rheumatoid arthritis	0.000255	0.000557	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—POMC—rheumatoid arthritis	0.000253	0.000554	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PLB1—rheumatoid arthritis	0.000253	0.000553	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—STAT1—rheumatoid arthritis	0.00025	0.000547	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CCL2—rheumatoid arthritis	0.000248	0.000542	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—IL6R—rheumatoid arthritis	0.000247	0.00054	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CXCL10—rheumatoid arthritis	0.000247	0.00054	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—UBE2D1—rheumatoid arthritis	0.000241	0.000526	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CXCL12—rheumatoid arthritis	0.000236	0.000516	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—BDKRB2—rheumatoid arthritis	0.000236	0.000516	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—POMC—rheumatoid arthritis	0.000236	0.000515	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—IL6ST—rheumatoid arthritis	0.000234	0.000512	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—ADRBK1—rheumatoid arthritis	0.000233	0.00051	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—MMP3—rheumatoid arthritis	0.000225	0.000492	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—TYK2—rheumatoid arthritis	0.000225	0.000492	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—MED1—rheumatoid arthritis	0.000222	0.000484	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—RASGRP1—rheumatoid arthritis	0.00022	0.000481	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—SYK—rheumatoid arthritis	0.00022	0.00048	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PTK2—rheumatoid arthritis	0.000217	0.000474	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CXCL8—rheumatoid arthritis	0.000216	0.000472	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PRKCQ—rheumatoid arthritis	0.000215	0.000471	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—POMC—rheumatoid arthritis	0.000214	0.000468	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CCL5—rheumatoid arthritis	0.000213	0.000465	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—STAT1—rheumatoid arthritis	0.000212	0.000463	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CCL2—rheumatoid arthritis	0.00021	0.000458	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CSF2—rheumatoid arthritis	0.000209	0.000458	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—IL6R—rheumatoid arthritis	0.000209	0.000457	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CXCL10—rheumatoid arthritis	0.000209	0.000456	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—IL2—rheumatoid arthritis	0.000206	0.000451	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—B3GNT2—rheumatoid arthritis	0.000206	0.00045	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ACP5—rheumatoid arthritis	0.000206	0.00045	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—SPP1—rheumatoid arthritis	0.000197	0.00043	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CXCL8—rheumatoid arthritis	0.000196	0.000428	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CCR5—rheumatoid arthritis	0.000192	0.000419	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—MMP3—rheumatoid arthritis	0.00019	0.000416	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—TYK2—rheumatoid arthritis	0.00019	0.000416	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—IL2RA—rheumatoid arthritis	0.000189	0.000413	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—IL2—rheumatoid arthritis	0.000187	0.000409	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—C3—rheumatoid arthritis	0.000187	0.000409	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—BGN—rheumatoid arthritis	0.000186	0.000406	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PTK2—rheumatoid arthritis	0.000183	0.0004	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CXCL8—rheumatoid arthritis	0.000182	0.000399	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CCL5—rheumatoid arthritis	0.00018	0.000393	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CSF2—rheumatoid arthritis	0.000177	0.000387	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—IL2—rheumatoid arthritis	0.000174	0.000381	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—LEP—rheumatoid arthritis	0.000174	0.000381	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ALOX5—rheumatoid arthritis	0.000171	0.000373	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—SPP1—rheumatoid arthritis	0.000166	0.000364	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CXCL8—rheumatoid arthritis	0.000166	0.000362	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—FN1—rheumatoid arthritis	0.000164	0.000359	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—IL6ST—rheumatoid arthritis	0.000164	0.000358	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CCR5—rheumatoid arthritis	0.000162	0.000354	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—IL2RA—rheumatoid arthritis	0.00016	0.000349	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—IL2—rheumatoid arthritis	0.000158	0.000346	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—C3—rheumatoid arthritis	0.000158	0.000346	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CD80—rheumatoid arthritis	0.000158	0.000344	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—POMC—rheumatoid arthritis	0.00015	0.000327	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—LEP—rheumatoid arthritis	0.000147	0.000322	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CCL2—rheumatoid arthritis	0.000146	0.00032	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—IL6R—rheumatoid arthritis	0.000146	0.000319	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ENO1—rheumatoid arthritis	0.000139	0.000304	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—FN1—rheumatoid arthritis	0.000139	0.000304	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—IL6ST—rheumatoid arthritis	0.000138	0.000302	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CD80—rheumatoid arthritis	0.000133	0.000291	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—TYK2—rheumatoid arthritis	0.000133	0.000291	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—NOS3—rheumatoid arthritis	0.000131	0.000285	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—POMC—rheumatoid arthritis	0.000126	0.000276	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CCL2—rheumatoid arthritis	0.000124	0.000271	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—IL6R—rheumatoid arthritis	0.000123	0.00027	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CXCL8—rheumatoid arthritis	0.000116	0.000253	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—TYK2—rheumatoid arthritis	0.000112	0.000246	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—IL2—rheumatoid arthritis	0.000111	0.000242	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NOS3—rheumatoid arthritis	0.00011	0.000241	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—IL6—rheumatoid arthritis	0.00011	0.000241	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—MMP9—rheumatoid arthritis	0.000105	0.000229	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—NFKB1—rheumatoid arthritis	0.000104	0.000226	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—MAPK8—rheumatoid arthritis	0.000102	0.000223	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CAT—rheumatoid arthritis	0.0001	0.000219	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CXCL8—rheumatoid arthritis	9.79e-05	0.000214	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—VEGFA—rheumatoid arthritis	9.4e-05	0.000206	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—IL2—rheumatoid arthritis	9.35e-05	0.000204	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—IL6—rheumatoid arthritis	9.3e-05	0.000203	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—MMP9—rheumatoid arthritis	8.85e-05	0.000193	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NFKB1—rheumatoid arthritis	8.76e-05	0.000191	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—TGFB1—rheumatoid arthritis	8.63e-05	0.000189	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—MAPK8—rheumatoid arthritis	8.61e-05	0.000188	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—MTHFR—rheumatoid arthritis	8.36e-05	0.000183	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—VEGFA—rheumatoid arthritis	7.95e-05	0.000174	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—TGFB1—rheumatoid arthritis	7.29e-05	0.000159	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—TP53—rheumatoid arthritis	7.11e-05	0.000155	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—POMC—rheumatoid arthritis	6.69e-05	0.000146	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—IL6—rheumatoid arthritis	6.5e-05	0.000142	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ALB—rheumatoid arthritis	6.1e-05	0.000133	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—TP53—rheumatoid arthritis	6e-05	0.000131	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—NOS3—rheumatoid arthritis	5.83e-05	0.000127	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—IL6—rheumatoid arthritis	5.5e-05	0.00012	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PTGS2—rheumatoid arthritis	5.33e-05	0.000117	CbGpPWpGaD
